Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats

Parkinsonian Rotenone Mouse Model: Reevaluation of Long-Term Administration of Rotenone in C57BL/6 Mice

(2011) Masatoshi Inden et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Human DJ-1-specific Transcriptional Activation of Tyrosine Hydroxylase Gene

(2010) Shizuma Ishikawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway

(2010) H. Aleyasin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oxidative Neurodegeneration Is Prevented by UCP0045037, an Allosteric Modulator for the Reduced Form of DJ-1, a Wild-Type of Familial Parkinson’s Disease-Linked PARK7

(2009) Koichiro Yamane et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Oxidative Status of DJ-1-dependent Activation of Dopamine Synthesis through Interaction of Tyrosine Hydroxylase and 4-Dihydroxy-l-phenylalanine (l-DOPA) Decarboxylase with DJ-1

(2009) Shizuma Ishikawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Induction of Parkinson Disease-Related Proteins in Motor Neurons after Transient Spinal Cord Ischemia in Rabbits

(2009) Masahiro Sakurai et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Protection Against Oxidative Stress-Induced Neurodegeneration by a Modulator for DJ-1, the Wild-Type of Familial Parkinson’s Disease-Linked PARK7

(2009) Takashi Yanagida et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson’s disease model rats

(2008) Shin Miyazaki et al.   JOURNAL OF NEUROCHEMISTRY

DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age

(2008) Steven J. Mullett et al.   NEUROPATHOLOGY